Search Within

Gavril W Pasternak

Formats
  1. Journal Article (309)
  2. Meeting Abstract (83)
  3. Book Section (12)
  4. Conference Paper (8)
  5. Book Whole (1)
  6. Editorial (1)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (414)
  2. Sloan Kettering Institute Faculty (414)
  3. Sloan Kettering Institute Postdocs (35)
  4. GSK Faculty (7)
  5. Center for Molecular Imaging and Biotechnology (5)
  6. Adult Leukemia (3)

More Groups

People
  1. Yingxian Pan (108)
  2. Grace Rossi (59)
  3. Jin Xu (53)
  4. Susruta Majumdar (42)
  5. Yuri Kolesnikov (30)
  6. Kelly Standifer (29)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2021 (5)
  4. 2020 (4)
  5. 2019 (6)
  6. 2018 (9)

More Years

Publications
  1. Society for Neuroscience Abstracts (44)
  2. Journal of Pharmacology and Experimental Therapeutics (41)
  3. Brain Research (28)
  4. European Journal of Pharmacology (27)
  5. Society for Neuroscience Abstract Viewer and Itinerary Planner (17)
  6. Life Sciences (16)

More Publications

Publishers
  1. Society for Neuroscience (64)
  2. Elsevier Science, Inc. (46)
  3. American Society for Pharmacology and Experimental Therapeutics (41)
  4. Elsevier Inc. (34)
  5. Elsevier B.V. (28)
  6. American Chemical Society (21)

More Publishers

Results (414)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • μ and δ opioid synergy between the periaqueductal gray and the rostro-ventral medulla
    Journal Article

    Rossi, G. C.; Pasternak, G. W.; Bodnar, R. J.
    Brain Research (1994)

    Fulltext@MSK | Save
  • Progress in opiate pharmacology
    Conference Paper

    Pasternak, G. W.
    Raven Press, Ltd. (1993)

    Fulltext@MSK | Save
  • Antagonist effects of β-funaltrexamine and naloxonazine on alfentanil-induced antinociception and muscle rigidity in the rat
    Journal Article

    Negus, S. S.; Pasternak, G. W.; Koob, G. F.; Weinger, M. B.
    Journal of Pharmacology and Experimental Therapeutics (1993)

    Fulltext@MSK | Save
  • Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats
    Journal Article

    Negus, S. S.; Henriksen, S. J.; Mattox, A.; Pasternak, G. W.; Portoghese, P. S.; Takemori, A. E.; Weinger, M. B.; Koob, G. F.
    Journal of Pharmacology and Experimental Therapeutics (1993)

    Fulltext@MSK | Save
  • Blockade of tolerance to morphine but not to κ opioids by a nitric oxide synthase inhibitor
    Conference Paper

    Kolesnikov, Y. A.; Pick, C. G.; Ciszewska, G.; Pasternak, G. W.
    National Academy of Sciences (1993)

    Fulltext@MSK | Save
  • Pharmacological mechanisms of opioid analgesics
    Journal Article

    Pasternak, G. W.
    Clinical Neuropharmacology (1993)

    Fulltext@MSK | Save
  • Blockade of mu and kappa(1) opioid analgesic tolerance by NPC17742, a novel NMDA antagonist
    Journal Article

    Kolesnikov, Y. A.; Ferkany, J.; Pasternak, G. W.
    Life Sciences (1993)

    Fulltext@MSK | Save
  • Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains
    Journal Article

    Pick, C. G.; Nejat, R. J.; Pasternak, G. W.
    Journal of Pharmacology and Experimental Therapeutics (1993)

    Fulltext@MSK | Save
  • Modulation of Mu(1) opioid binding by magnesium: Evidence for multiple receptor conformations
    Journal Article

    Standifer, K. M.; Clark, J. A.; Pasternak, G. W.
    Journal of Pharmacology and Experimental Therapeutics (1993)

    Fulltext@MSK | Save
  • Functional antagonism of morphine analgesia by (+)-pentazocine: Evidence for an anti-opioid σ(1) system
    Journal Article

    Chien, C. C.; Pasternak, G. W.
    European Journal of Pharmacology (1993)

    Fulltext@MSK | Save